Earlier this year, patients treated by an AI chatbot for some common mental health challenges got better. This was significant because the patients were part of the first randomized and controlled trial for this type of AI intervention. 

Some infusion systems manufactured by Zyno Medical were released with unapproved software that could cause safety features to malfunction. Use of any device subject to the recall is to cease immediately. 

“Just as medicine has its own language, so does business," two surgeons explained in a new editorial. 

Even TAVR patients not treated using transfemoral access can typically go home the very next day. 

The EARLY TAVR clinical trial made a significant impact, paving the way for the FDA to approve multiple transcatheter heart valves for the treatment of asymptomatic patients. However, one cardiologist who participated in the trial has some serious concerns with how its findings were presented to the public. 

The Joint Commission is partnering with the Coalition for Health AI to scale AI accountability. The project will supply more than 80% of U.S. provider orgs with gameplans, toolkits and overall guidance. 

To maximize returns on AI investments, healthcare organizations should align AI initiatives with core competencies. The effort should focus on optimizing experiences for workforces as well as patients. 

One of the picks for the Advisory Committee on Immunization Practices, Robert Malone, MD, is known for his outspoken criticism of mRNA vaccines, particularly for COVID-19. Malone believes the technology is unsafe and has been accused by public health officials of spreading medical misinformation.